Patents
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
08/2003
08/27/2003EP1338591A1 Method for synthesis of (2S,3aS,7aS)-perhydroindole-2- carboxylic acid and esters thereof, and use in the synthesis of perindopril
08/27/2003EP1338588A1 Method of resolving optical isomers of amino acid derivative
08/27/2003EP1338336A1 Catalysts comprising n-substituted cyclic imides and processes for preparing organic compounds with the catalysts
08/27/2003EP1337590A1 Efficient cyclic-bridged cyanine dyes
08/27/2003EP1337511A1 Bis-heterocyclic compounds with antitumour and chemosensitising activity
08/27/2003EP1189902B1 7-oxo-2-azabicyclo[2.2.1]heptanes as selective muscarinic receptor antagonist
08/27/2003EP0988057B1 Bioreductive conjugates for drug targeting
08/27/2003EP0901469B1 Arylalkylpiperazine compounds as antioxidants
08/27/2003EP0874809B1 Carbamoyloxy derivatives of mutiline and their use as antibacterials
08/27/2003EP0862552B1 Succinimide and maleimide cytokine inhibitors
08/27/2003CN1439006A Novel compounds possessing antibacterial, antifungal or antitumor activity
08/27/2003CN1439005A Pyrrole substituted 2-indolinone protein kinase inhibitors
08/27/2003CN1438993A Ethylenediamine derivatives
08/27/2003CN1438991A Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase
08/27/2003CN1438639A Otical recording material
08/27/2003CN1119329C Method of purifying carbazole ester precursors of 6-chloro-alpha-methy-carbazole-2-acetic acid
08/27/2003CN1119328C Acylaminoalkenylene-amide derivatives as NK1 and NK2 antagonists
08/26/2003US6610854 Reacting (Z)-5-Fluoro-2-methyl-(4-pyridylidene)-3-(N-benzyl) indenylacetamide with hydrochloric acid to produce (Z)-5-fluoro-2-methyl-(4-pyridylidene)-3-(N-benzyl)indenylacetamide hydrochloride
08/26/2003US6610731 Antiinflammatory
08/26/2003US6610729 Hydroxamic acid derivatives and medicinal utilization thereof
08/26/2003US6610702 Ammonium salts of inositol hexaphosphate, and uses thereof
08/26/2003US6610689 Viricides
08/23/2003CA2473075A1 Process for the manufacture of hmg-coa reductase inhibitory mevalonic acid derivatives
08/21/2003WO2003069411A1 Visible radiation sensitive composition
08/21/2003WO2003069350A2 Small molecule modulators of apoptosis
08/21/2003WO2003068837A1 Indole resins, epoxy resins and resin compositions containing the same
08/21/2003WO2003068752A1 Benzenesulfonamide derivatives as antipsychotic agents
08/21/2003WO2003068751A1 7-arylsulfonamido-2,3,4,5-tetrahydro-1h-benzo'diazepine derivatives with 5-ht6 receptor affinity for the reatment of cns disorders
08/21/2003WO2003068742A1 Synthesis of indole thiazole compounds as ligands for the ah receptor
08/21/2003WO2003068741A1 Indole derivatives substituted with long-chain alcohols and medicaments containing them
08/21/2003WO2003068740A1 Pyrrolylalkylidene-hydrazinecarboximidamide derivatives as 5-hydroxytryptamine-6 ligands
08/21/2003WO2003068732A2 Benzenesulfonamide derivatives and their use as dopamine d3 and d2 receptor liga ds
08/21/2003WO2003068242A1 Phospholipids as caspase inhibitor prodrugs
08/21/2003WO2003068220A1 1-arylsulfonyl-3-substituted indole and indoline derivatives useful in the treatment of central nervous system disorders
08/21/2003WO2003068212A1 Use of sodium/hydrogen exchange inhibitors from the treatment of thrombotic and inflammatory diseases
08/21/2003WO2003068157A2 Kinase inhibitors and methods of use thereof
08/21/2003WO2002100847A3 Factor xa inhibitor
08/21/2003WO2002020463A3 Fxr modulators
08/21/2003WO2002002512A3 Compounds to treat alzheimer's disease
08/21/2003US20030158417 Indole type compound derivatives for use as antiinflammation or antiproliferative agents, treating cardiovascular disorders, Alzheimer's disease
08/21/2003US20030158405 N-benzhydryl indole compounds
08/21/2003US20030158256 (Arylaminoaceamido)acetonitrile derivatives
08/21/2003US20030158252 Especially trypsin-like serine proteases, such as chymotrypsin, trypsin, thrombin, plasmin and factor Xa.
08/21/2003US20030158246 For the treatment of prostaglandin mediated diseases, such as allergic asthma or rhinitis.
08/21/2003US20030158231 Sulfonamide compounds as protease inhibitors
08/21/2003US20030158225 Novel compounds
08/21/2003US20030158222 2-3-dihydro-1H-isoindole derivatives useful as modulators of dopamine D3 receptors (an-tipsychotic agents)
08/21/2003US20030158216 2-acyl indole derivatives and their use as antitumor agents
08/21/2003US20030158215 Tyrosine kinase inhibitors
08/21/2003US20030158209 Amidomethylcarbonyl-substituted piperazine derivatives containing additional amine groups, useful in treating eating, sexual and skin disorders
08/21/2003US20030158208 Dopamine D4 ligands for the treatment of novelty-seeking disorders
08/21/2003US20030158198 Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor
08/21/2003US20030158188 An antagonists for treating pain, inflammations, urinary incontinence and bladder overactivity
08/21/2003US20030158177 Treating or preventing obesity
08/21/2003US20030158155 Mmp-12 inhibitors
08/21/2003US20030158152 Protease inhibitors and their pharmaceutical uses
08/21/2003US20030158127 Aromatic sulfenates for type I phototherapy
08/21/2003US20030158121 Novel $G(y)crystalline form of perindopril tert- butylamine salt, preparation method, and pharmaceutical compositions containing same
08/21/2003US20030155299 Caprolactam from aminocapronitrile; extraction, distillation
08/21/2003CA2476446A1 Use of sodium/hydrogen exchange inhibitors from the treatment of thrombotic and inflammatory diseases
08/21/2003CA2475783A1 Benzenesulfonamide derivatives as antipsychotic agents
08/21/2003CA2372785A1 Pharmaceutical combination of angiotensin ii antagonists and angiotensin i converting enzyme inhibitors
08/20/2003EP1336604A1 Sulfoximine derivatives as MMP-inhibitors or antibiotics
08/20/2003EP1335988A2 Synthesis of chiral intermediates useful in preparing pharmacologically active compounds
08/20/2003EP1335920A2 Small molecule compositions for binding to hsp90
08/20/2003EP1335901A1 Pharmaceutically active sulfanilide derivatives
08/20/2003EP1335898A1 Carbamic acid compounds comprising an amide linkage as hdac inhibitors
08/20/2003EP1335895A2 Protease inhibitors and their pharmaceutical uses
08/20/2003EP1335722A2 Compounds useful in the treatment of cns disorders
08/20/2003EP1335720A1 Sulphonamides for the treatment of central nervous system diseases
08/20/2003EP1263504B1 Use of compounds with 5-ht1a activity useful for treating disorders of the outer retina
08/20/2003EP1173519B1 Novel carbopyronine fluorescence dyes
08/20/2003EP1150944B1 N2-phenylamidine derivatives
08/20/2003EP0923542B1 Aryl substituted cyclic amines as selective dopamine d3 ligands
08/20/2003EP0831829B1 Heterocyclic ring-fused pyrimidine derivatives
08/20/2003CN1437598A Novel indole derivatives
08/20/2003CN1437597A Substituted phenyl-Piperazine derivatives, their preparation and use
08/20/2003CN1437596A Phenylpiperazinyl derivatives
08/20/2003CN1437581A Glucagon antagonists/inverse agonists
08/20/2003CN1437484A New formulation comprising a beta-blocker and optionally a cholesterol-lowering agent
08/20/2003CN1118451C Acylated derivatives of melatonin and its analogues as medicine
08/19/2003US6608715 Wavelength converter using Bragg-grating
08/19/2003US6608227 Benzylcycloalkyl amines as modulators of chemokine receptor activity
08/19/2003US6608100 HIV protease inhibitors based on amino acid derivatives
08/19/2003US6608099 Indole sPLA2 inhibitors
08/19/2003US6608084 Treatment of human or non-human animal patient suffering from, or subject to, condition which can be ameliorated by administration of inhibitor of alpha 4 beta 1 mediated cell adhesion
08/19/2003US6608070 Useful for treatment of medical condition in which prostaglandins are implicated as pathogens
08/19/2003US6608068 Substituted indoline derivative compounds which are antagonists of the progesterone receptor; contraceptives; antineoplastic agents
08/14/2003WO2003067332A2 Sulfonate derivatives and the use therof as latent acids
08/14/2003WO2003066889A2 Assay for acytyltransferase or deacetylase activity
08/14/2003WO2003066628A1 Oxadiazoles having antiproliferative activity
08/14/2003WO2003066597A2 Guanidino compounds
08/14/2003WO2003066579A2 Novel bicyclic hydroxamates as inhibitors of histone deacetylase
08/14/2003WO2003066574A1 Aromatic amino acid derivatives and medicinal compositions
08/14/2003WO2003066570A1 Transition-metal-catalyzed carbon-nitrogen bond-forming methods using carbene ligands
08/14/2003WO2003065989A2 (oxime)carbamoyl fatty acid amide hydrolase inhibitors
08/14/2003WO2003065789A2 N-biphenylmethyl aminocycloalkanecarboxamide derivatives
08/14/2003US20030153770 Novel sPLA2 inhibitors
08/14/2003US20030153763 Indolinyl, 1,2,3,4-tetrahydroquinolinyl, 1,2,3,4-tetrahydro isoquinolinyl, benz(cd)indolinyl and 5,6-dihydrophen anthridinyl compounds; treating neurodegenerative disorders
08/14/2003US20030153754 Gamma-aminobutyric acid (gaba); anxiolytic agents, treating sleep and seizure disorders